Analyst, Investment Banking - Mergers and Acquisitions

TD Bank•Dallas, TX

9d•Onsite

About The Position

The Investment Banking Analyst provides financial, strategic, and execution support on mergers and acquisitions involving biotechnology and life sciences companies. The role is highly analytical, with a primary focus on financial modeling, valuation, transaction analysis, due diligence, and the preparation of materials for live M&A engagements. The Analyst will work as an integral member of M&A transaction teams advising biotechnology, pharmaceutical, and life sciences clients. This role involves building and maintaining complex operating, valuation, and transaction models, including DCF, probability-adjusted pipeline, sum-of-the-parts, merger, accretion / dilution, purchase price allocation, and scenario analyses. The Analyst will develop biotechnology-specific forecasts incorporating clinical timelines, probability of success, market opportunity, pricing, patent exclusivity, competition, and product lifecycle assumptions. They will evaluate potential acquirers, targets, transaction structures, strategic alternatives, consideration mixes, financing assumptions, ownership, dilution, and pro forma financial impacts. The role requires analyzing public and private companies, including financial performance, capital structure, liquidity, clinical pipelines, regulatory milestones, commercial outlook, and strategic fit. Conducting detailed diligence across therapeutic areas, clinical data, regulatory pathways, intellectual property, market dynamics, competitive positioning, and M&A precedents is also a key responsibility. The Analyst will prepare valuation materials, board presentations, management presentations, process letters, bid analyses, transaction summaries, and other materials for live M&A engagements. Coordination of financial, legal, regulatory, commercial, and scientific diligence, and maintenance of transaction models, data rooms, trackers, and other execution workstreams are essential. The role demands exceptional accuracy, responsiveness, judgment, confidentiality, and attention to detail under demanding transaction timelines.

Requirements

Advanced Excel proficiency and the ability to build, audit, and explain complex biotechnology operating and M&A models from first principles.
Strong understanding of biotechnology valuation, drug development, clinical and regulatory risk, M&A structures, and transaction mechanics.
Ability to translate scientific, clinical, commercial, and transaction information into defensible assumptions and clear client conclusions.
High standards of analytical rigor, ownership, and execution across multiple live M&A workstreams.
Undergraduate degree with strong academic performance in Finance, Accounting, Economics, Mathematics, Engineering, Biology, Chemistry, Biochemistry, or a related field.
0-3 years of relevant experience in investment banking, transaction advisory, equity research, healthcare investing, or a related analytical role.
Demonstrated interest in biotechnology, pharmaceuticals, healthcare, and M&A.
Advanced Excel and PowerPoint proficiency.
Applicable securities licenses required.

Responsibilities

Provides financial, strategic, and execution support on mergers and acquisitions involving biotechnology and life sciences companies.
Builds and maintains complex operating, valuation, and transaction models, including DCF, probability-adjusted pipeline, sum-of-the-parts, merger, accretion / dilution, purchase price allocation, and scenario analyses.
Develops biotechnology-specific forecasts incorporating clinical timelines, probability of success, market opportunity, pricing, patent exclusivity, competition, and product lifecycle assumptions.
Evaluates potential acquirers, targets, transaction structures, strategic alternatives, consideration mixes, financing assumptions, ownership, dilution, and pro forma financial impacts.
Analyzes public and private companies, including financial performance, capital structure, liquidity, clinical pipelines, regulatory milestones, commercial outlook, and strategic fit.
Conducts detailed diligence across therapeutic areas, clinical data, regulatory pathways, intellectual property, market dynamics, competitive positioning, and M&A precedents.
Prepares valuation materials, board presentations, management presentations, process letters, bid analyses, transaction summaries, and other materials for live M&A engagements.
Coordinates financial, legal, regulatory, commercial, and scientific diligence and maintains transaction models, data rooms, trackers, and other execution workstreams.
Maintains exceptional accuracy, responsiveness, judgment, confidentiality, and attention to detail under demanding transaction timelines.